(Press-News.org) CAMBRIDGE, MA -- Diagnosing sleep disorders such as sleep apnea usually requires a patient to spend the night in a sleep lab, hooked up to a variety of sensors and monitors. Researchers from MIT, Celero Systems, and West Virginia University hope to make that process less intrusive, using an ingestible capsule they developed that can monitor vital signs from within the patient’s GI tract.
The capsule, which is about the size of a multivitamin, uses an accelerometer to measure the patient’s breathing rate and heart rate. In addition to diagnosing sleep apnea, the device could also be useful for detecting opioid overdoses in people at high risk, the researchers say.
“It’s an exciting intervention to help people be diagnosed and then receive the appropriate treatment if they suffer from obstructive sleep apnea,” says Giovanni Traverso, an associate professor of mechanical engineering at MIT and a gastroenterologist at Brigham and Women’s Hospital. “The device also has the potential for early detection of changes in respiratory status, whether it’s a result of opiates or other conditions that could be monitored, like asthma or chronic obstructive pulmonary disease (COPD).”
In a study of 10 human volunteers, the researchers showed that the capsule can be used to monitor vital signs and to detect sleep apnea episodes, which occur when the patient repeatedly stops and starts breathing during sleep. The patients did not show any adverse effects from the capsule, which passed harmlessly through the digestive tract.
Traverso is one of the senior authors of the study, along with Robert Langer, an MIT Institute Professor and member of MIT’s Koch Institute for Integrative Cancer Research; Victor Finomore, director of the Human Performance and Applied Neuroscience Research Center at the West Virginia University School of Medicine; and Ali Rezai, director of the Rockefeller Neuroscience Institute at the West Virginia University School of Medicine. The paper appears today in the journal Device.
Vital sign measurements
Over the past decade, Traverso and Langer have developed a range of ingestible sensors that could be used to monitor vital signs and diagnose disorders of the GI tract, such as gastrointestinal slowdown and inflammatory bowel diseases.
This new study focused on measuring vital signs, using a capsule developed by Celero Systems that includes an accelerometer that detects slight movements generated by the beating of the heart and the expansion of the lungs. The capsule also contains two small batteries and a wireless antenna that transmits data to an external device such as a laptop.
In tests in an animal model, the researchers found that this capsule could accurately measure breathing rate and heart rate. In one experiment, they showed that the sensor could detect the depression of breathing rate that resulted from a large dose of fentanyl, an opioid drug.
Building on those results, the researchers decided to further test the capsule in a clinical trial at the West Virginia University Rockefeller Neuroscience Institute. Ten patients who enrolled in the study were monitored using the ingestible capsule, and these patients were also connected to the sensors typically used to monitor sleep, so the researchers could compare measurements from both types of sensors.
The researchers found that their ingestible sensor was able to accurately measure both breathing rate and heart rate, and it also detected a sleep apnea episode that one of the patients experienced.
“What we were able to show is that using the capsule, we could capture data that matched what the traditional transdermal sensors would capture,” Traverso says. “We also observed that the capsule could detect apnea, and that was confirmed with standard monitoring systems that are available in the sleep lab.”
In this study, the researchers monitored signals emitted by the capsule while it was in the stomach, but in a previous study, they showed that vital signs can also be measured from other parts of the GI tract.
“The stomach generally offers some of the best signals, mainly because it’s close to the heart and the lungs, but we know that we can also sense them elsewhere,” Traverso says.
None of the patients reported any discomfort or harm from the capsule. Radiographic imaging performed 14 days after the capsules were ingested revealed that all of them had passed through the patients’ bodies. The research team’s previous work has shown that objects of similar size usually move through the digestive tract in a little more than a day.
The researchers envision that this kind of sensor could be used to diagnose sleep apnea in a less intrusive way than the skin-based sensors that are now used. It could also be used to monitor patients when they begin treatment for apnea, to make sure that the treatments are effective.
Celero Systems, a company founded by Traverso, Langer, Jeremy Ruskin, a professor of medicine at Harvard Medical School, and Benjamin Pless, now CEO of the company, is now working on sensors that could be used to detect sleep apnea or opioid overdose.
“We know that people who have had an overdose are at higher risk of recurrence, so those individuals could be monitored more closely so that in the event of another overdose, someone could help them,” Traverso says.
In future work, the researchers hope to incorporate an overdose reversal agent such as nalmefene into the device, so that drug release would be triggered when the person’s breathing rate slowed or stopped. They are also working on strategies to lengthen the amount of time that the capsules could remain in the stomach.
The research was funded by the Karl van Tassel Career Professorship, MIT’s Department of Mechanical Engineering, and Celero Systems.
Authors of the paper also include Pless, James Mahoney, Justin Kupec, Robert Stansbury, Daniel Bacher, Shannon Schuetz, and Alison Hayward.
Ingestible electronic device detects breathing depression in patients
The new sensor measures heart and breathing rate from patients with sleep apnea and could also be used to monitor people at risk of opioid overdose
ELSE PRESS RELEASES FROM THIS DATE:
Higher-dose fluvoxamine and time to sustained recovery in outpatients with COVID-19
About The Study: Among outpatient adults with mild to moderate COVID-19, treatment with fluvoxamine 100 mg twice daily for 13 days, compared with placebo, did not improve time to sustained recovery in this randomized clinical trial of 1,175 participants. Authors: Susanna Naggie, M.D., M.H.S., of the Duke University School of Medicine in Durham, North Carolina, is the corresponding author. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jama.2023.23363) Editor’s Note: Please see the article for additional information, ...
Educational outcomes for children at 7 to 9 years of age after birth at 39 vs 40 to 42 weeks’ gestation
About The Study: In this study of 155,000 births, using a causal inference framework based on target trial emulation, birth at 39 weeks’ gestation was not associated with adverse numeracy and literacy outcomes at school age compared with birth at 40 to 42 weeks. Authors: Roxanne Hastie, Ph.D., of the University of Melbourne, is the corresponding author. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamanetworkopen.2023.43721) Editor’s Note: Please see the article for ...
State reporting requirements for involuntary holds, court-ordered guardianship, and the national firearm background check system
About The Study: In this study of state laws, there was substantial heterogeneity in National Instant Criminal Background Check System (NICS) reporting requirements for mental health prohibitions for firearm possession and a lack of clarity around processes. This raises questions about the ability of NICS to be used to block firearm purchases or possession by individuals with court-identified high risk of perpetrating violence toward themselves or others. Authors: Marian E. Betz, M.D., M.P.H., of the University of Colorado Anschutz Medical Campus School of Medicine in Aurora, is the ...
Benefits of adolescent fitness to future cardiovascular health possibly overestimated
There is a well-known relationship between good physical fitness at a young age and a lower risk of cardiovascular disease later in life. However, when researchers adjusted for familial factors by means of sibling analysis, they found a weaker association, although the link between high body mass index (BMI) and cardiovascular disease remained strong. The study, which was conducted by researchers from Karolinska Institutet and other universities, is published in JAMA Network Open. “This does not mean that fitness is irrelevant,” ...
Following a Mediterranean diet reduces the risk of cognitive decline in older people
Old people who follow a Mediterranean diet are at a lower risk of cognitive decline, according to a study published in the journal Molecular Nutrition and Food Research. The study provides new evidence for a better understanding of the biological mechanisms related to the impact of the diet on cognitive health in the ageing population. The study is led by Mireia Urpí-Sardá, adjunct lecturer and member of the Biomarkers and Nutritional & Food Metabolomics research group of the Faculty of Pharmacy and Food Sciences, the Institute for Nutrition and Food Safety (INSA-UB), the Food and Nutrition Torribera Campus of the University of Barcelona, and the CIBER on Frailty and ...
A deep-sea fish inspired researchers to develop supramolecular light-driven machinery
The vision system, evolved over millions of years, is highly complex. To make vision sensitive throughout the whole range of visible wavelengths, Nature employs a supramolecular chemistry approach. The visual pigment, cis-retinal, changes its shape upon capturing a photon. This shape transformation is accompanied by changes in the supramolecular organization of the surrounding proteins, subsequently triggering a cascade of chemical signaling events that get amplified and eventually lead to visual perception in the brain. “Some deep-sea fish have evolved antenna-like ...
Shedding light on unique conduction mechanisms in a new type of perovskite oxide
The remarkable proton and oxide-ion (dual-ion) conductivities of hexagonal perovskite-related oxide Ba7Nb3.8Mo1.2O20.1 are promising for next-generation electrochemical devices, as reported by scientists at Tokyo Tech. The unique ion-transport mechanisms they unveiled will hopefully pave the way for better dual-ion conductors, which could play an essential role in tomorrow’s clean energy technologies. Clean energy technologies are the cornerstone of sustainable societies, and solid-oxide fuel cells (SOFCs) and proton ceramic fuel cells (PCFCs) are among the most promising types of electrochemical devices for green power generation. These devices, however, still ...
UK’s Rural Physician Leadership Program, Anthem Medicaid announce new rural medicine scholarships
MOREHEAD, Ky. (Nov. 17, 2023) — In celebration of National Rural Health Day, yesterday the University of Kentucky College of Medicine and Anthem Blue Cross and Blue Shield Medicaid in Kentucky announced new scholarship opportunities for UK’s Rural Physician Leadership Program (RPLP). The Anthem Rural Medicine Scholarships will provide $100,000 to offset the cost of medical school for students in the RPLP. In a state that suffers from high rates for many chronic, ...
Heart repair via neuroimmune crosstalk
Unlike humans, zebrafish can completely regenerate their hearts after injury. They owe this ability to the interaction between their nervous and immune systems, as researchers led by Suphansa Sawamiphak from the Max Delbrück Center now report in the journal Developmental Cell. Each year, more than 300,000 people in Germany have a myocardial infarction – the technical term for heart attack. The number of people surviving a heart attack has increased significantly, but this severe cardiac event causes irreparable damage to their hearts. A heart attack ...
BU researchers develop new method to help with analysis of single cell data
(Boston)—CITE-seq (cellular indexing of transcriptomes and epitopes) is an RNA sequencing-based method that simultaneously quantifies cell surface protein and transcriptomic data within a single cell readout. The ability to study cells concurrently offers unprecedented insights into new cell types, disease states or other conditions. While CITE-seq solves the problem of detecting a limited number of proteins while using single-cell sequencing in an unbiased way, one of its limitations is the high levels of background noise that can hinder analysis. To rectify ...
LAST 30 PRESS RELEASES:
BioOne announces Subscribe to Open Pilot
Unveiling a new era of imaging: Boston University engineers lead breakthrough microscopy techniques
New wearable communication system offers potential to reduce digital health divide
In hotter regions, mammals seek forests, avoid human habitats
Leukemia cells activate cellular recycling program
Argonne and Idaho National Laboratories partner with CMBlu Energy for innovative long-duration energy storage project
CCNY researchers publish optical data storage breakthrough in Nature Nanotechnology
Diet has a major impact on risk of Alzheimer’s disease
Study shows how ethical brands fare in a recession
New technique efficiently offers insight into gene regulation
U of M Medical School study finds visions of nonphysical world are common among cognitively healthy Ojibwe individuals
Consistency key to corporate expressions of racial solidarity
How mountains affect El Niño-induced winter precipitation
ECHO research examines nutrition data's value from pregnancy to adolescence in understanding child health
Training the immune system to prevent cancer – NextGen researchers discover paradigm-shifting approach
Snail-inspired robot could scoop ocean microplastics
Georgia State professor granted $5 million to identify and characterize objects in space
Immune protein may induce dementia unrelated to high blood pressure
Q&A: How can Canada best meet its commitment to protecting 30% of its land by 2030?
Eating disorder hospitalizations on the rise, affecting 'atypical' groups the most
Brains of newborns aren't underdeveloped compared to other primates
Mortality and morbidity among individuals with hypertension receiving a diuretic, ace inhibitor, or calcium channel blocker
Types of on-screen content and mental health in kindergarten children
Maternal prenatal depressive symptoms and fetal growth during the critical rapid growth stage
About 20% of patients listed as alive in their electronic health records were actually deceased according to California data
Dietary environmental factors shape the immune defense against Cryptosporidium infection
New study maps ketamine's effects on brain
Studies help explain why some prostate cancers become resistant to hormone therapy
Hard to drug: Protein droplets reveal new ways to inhibit transcription factors in an aggressive form of prostate cancer
MD Anderson’s Katy Rezvani, M.D., receives 2023 Honorific Award from the American Society of Hematology[Press-News.org] Ingestible electronic device detects breathing depression in patients
The new sensor measures heart and breathing rate from patients with sleep apnea and could also be used to monitor people at risk of opioid overdose